![Shannon Campbell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 16 711 $ in data 30/09/2026
Ms. Shannon Campbell is an Independent Director at Black Diamond Therapeutics, Inc. She is on the Board of Directors at Hansa Biopharma AB, Zentalis Pharmaceuticals, Inc. and Black Diamond Therapeutics, Inc. Ms. Campbell was previously employed as a Chief Commercial Officer & Executive VP by Merus NV and a Vice President & General Manager-Oncology by Bayer HealthCare Pharmaceuticals, Inc. She received her undergraduate degree from Ithaca College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 26/06/2026 | 8.865 ( 0,02% ) | 16 711 $ | 30/09/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 10/04/2024 |
| ZENTALIS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 22/05/2026 |
| HANSA BIOPHARMA AB | Direttore/Membro del Consiglio | 22/09/2026 |
| Società | Posizione | Fine |
|---|---|---|
| MERUS N.V. | Corporate Officer/Principal | 01/01/2026 |
Bayer HealthCare Pharmaceuticals, Inc.
 Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Corporate Officer/Principal | 01/01/2017 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 6 |
|---|---|
Ithaca College
 Ithaca College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare Pharmaceuticals, Inc.
Bayer HealthCare Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drugs | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Hansa Biopharma AB
 Hansa Biopharma AB Pharmaceuticals: MajorHealth Technology Develops therapies and medicines for the treatment of immunomodulatory | Health Technology |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
